No near-term lifeline from China for Nvidia's H20 chips

Nvidia's anticipated recovery in China for its compliant H20 AI chips faces significant near-term hurdles, including production delays, pending export licenses, and supply chain constraints, leading to expectations of negligible revenue impact until Q4. Analysts caution that a material revenue contribution from China is unlikely before 2026, despite the company's strong year-to-date stock performance. This indicates a slow, methodical market rebuilding rather than immediate upside, shifting investor focus towards the future growth potential of Nvidia's next-generation Blackwell-based chips.

Analysis

Nvidia's planned resumption of H20 chip sales to China is facing significant near-term headwinds, tempering expectations for an immediate revenue boost. The recovery is projected to be slow and methodical, with Nvidia's own timeline indicating negligible revenue impact until at least the fourth quarter. This cautious outlook is reinforced by analysts from Morgan Stanley, Piper Sandler, and Rosenblatt, who highlight specific hurdles including pending U.S. export licenses, logistical setbacks from previously canceled orders, minimal finished inventory, and a nine-month supply chain ramp-up period. Morgan Stanley suggests a material revenue contribution from China is unlikely before 2026. Despite these challenges, Nvidia's stock has demonstrated strong performance, rising 24% year-to-date, which implies investor focus is increasingly shifting toward the long-term potential of its next-generation Blackwell-based chips rather than the immediate financial upside from the China market.

Key Decisions for Investors

• Investors should moderate near-term revenue expectations from the China segment, as both company and analyst guidance point to a negligible impact until late 2024 with more substantial contributions not expected until 2026.
• Monitor key catalysts that could alter this timeline, specifically the official issuance of U.S. export licenses for H20 chips and any company announcements on the resolution of supply chain constraints.
• Given the stock's 24% year-to-date gain, it is prudent to recognize that the market may be pricing in growth from the next-generation Blackwell platform, making developments in that area a more critical driver than the gradual China recovery.